Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Joanne C. Imperial"'
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 7, Pp 944-953 (2024)
Background and Aims: We quantified hepatic functional impairment using quantitative function tests and linked severity of functional impairment to liver-related complications and outcome in primary sclerosing cholangitis. Methods: Forty-seven patient
Externí odkaz:
https://doaj.org/article/c6563efb23cd4028a1c03a3542950488
Autor:
Claudia M. Filozof, Carolin Lackner, Manuel Romero-Gómez, Joanne C. Imperial, Robert McGee, Lara Dimick-Santos, Oscar Cummings, Cynthia Behling, Troy Johnson, Arun Sanyal
Publikováno v:
GastroHep. 2022:1-11
Background. In most clinical trials focusing on precirrhotic nonalcoholic steatohepatitis (NASH), a liver biopsy is required for confirmation of diagnosis, staging fibrosis, and grading steatohepatitis activity. Reliance on the biopsy, both as a requ
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 72:244-249
Background Endoscopic retrograde cholangiopancreatography (ERCP) is a fluoroscopy and endoscopy-based procedure important for diagnosis and management of pediatric pancreaticobiliary disorders. Patient, procedure, endoscopist and facility characteris
Autor:
Ethan M. Weinberg, Jean L. Chan, Joanne C. Imperial, James M. Robinson, Michael P. Curry, Catherine Frenette, Zachary Goodman, K. Rajender Reddy, Fredric G. Regenstein, Eugene R. Schiff
Publikováno v:
Liver Transplantation. 27:568-579
Despite achieving sustained virologic response (SVR) to hepatitis C virus (HCV) therapy, there remains a post liver transplantation population with advanced fibrosis/cirrhosis. Emricasan is an orally active, pan-caspase inhibitor that suppresses apop
Autor:
Alicia M. Cryer, Joanne C. Imperial
Publikováno v:
Clinics in Liver Disease. 23:451-462
Chronic hepatitis B is a global health problem affecting approximately 350 million to 400 million individuals worldwide, and mother to child transmission remains the major mode of transmission. Approximately 50% of chronically infected individuals ac
Autor:
Yuval A. Patel, Joanne C. Imperial, Andrew J. Muir, Quentin M. Anstee, David DeBrota, Lara Dimick-Santos, Claudia Filozof, Ruby Mehta, Arun J. Sanyal, Elmer Schabel, Brent A. Neuschwander-Tetri, Veronica Miller, Sander Bangma, Melanie Baxter, Sherif Boulos, Gary Burgess, Manu Chakravarthy, Rose Christian, Anthony Coombs, Goran Gannedahl, Richard Herrmann, Dean Hum, Joanne Imperial, Stuart Kendrick, Leigh MacConell, Sophie Megnien, Andrew Muir, Yuval Patel, Dan Peres, Stephen Rossi, Arun Sanyal, David Shapiro, Tim St Pierre, Michael Zemel
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease worldwide and is an increasing cause of liver-related morbidity and mortality. Nonalcoholic steatohepatitis (NASH), the progressive histological subtype of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2c0e8b8f543a51c1159349167e1f477
https://europepmc.org/articles/PMC5861348/
https://europepmc.org/articles/PMC5861348/
Autor:
Joanne C. Imperial, Terry L. Jue
Publikováno v:
Gastrointestinal Endoscopy. 67:886-889
Publikováno v:
Clinical Gastroenterology and Hepatology. 4:288-292
Autor:
Joanne C. Imperial
Publikováno v:
Journal of Gastroenterology and Hepatology. 14:S1-S5
Hepatitis B virus (HBV) affects more than 300 million individuals worldwide and in the United States approximately 1.25 million individuals are chronic carriers of HBV. The risk of becoming a chronic hepatitis B virus surface antigen carrier is depen
Publikováno v:
Journal of Gastroenterology and Hepatology. 14:S48-S52
To assess whether Asian race is an independent variable affecting survival and hepatitis B virus (HBV) recurrence after liver transplantation, the results of 27 consecutive liver transplants performed between June 1994 and April 1997 for HBV cirrhosi